Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 13, Number 7—July 2007

Research

Antimicrobial Drugs and Community-acquired Methicillin-Resistant Staphylococcus aureus, United Kingdom

Verena Schneider-Lindner*†, J. A. Delaney*†, Sandra Dial†‡, Andre Dascal‡, and Samy Suissa*†Comments to Author 
Author affiliations: *McGill University Health Center, Montreal, Quebec, Canada; †Royal Victoria Hospital, Montreal, Quebec, Canada; ‡Sir Mortimer B. Davis–Jewish General Hospital, Montreal, Quebec, Canada;

Main Article

Figure

Annual number of all study participants with methicillin-resistant Staphylococcus aureus (MRSA) recorded for the first time in the General Practice Research Database (GPRD) and no hospitalization in the past 24 months (vertical bars). The annual incidence rate of MRSA per 100,000 adults in the GPRD is indicated by the line above the bars. Data from the GPRD, United Kingdom, 2000–2004.

Figure. Annual number of all study participants with methicillin-resistant Staphylococcus aureus (MRSA) recorded for the first time in the General Practice Research Database (GPRD) and no hospitalization in the past 24 months (vertical bars). The annual incidence rate of MRSA per 100,000 adults in the GPRD is indicated by the line above the bars. Data from the GPRD, United Kingdom, 2000–2004.

Main Article

TOP